Societies

How does ESMO-MCBS v2.0 Reflect the Evolving Oncology Treatment Landscape?

ESMO/X

Aug 8, 2025, 14:19

How does ESMO-MCBS v2.0 Reflect the Evolving Oncology Treatment Landscape?

European Society for Medical Oncology (ESMO) shared a post on X:

“How does ESMO-MCBS v2.0 reflect the evolving oncology treatment landscape and the priorities of Patients With Cancer? Sjoukje Oosting shares her insights in the ESMO Daily Reporter.”

Title: ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)

Authors: N.I. Cherny, S.F. Oosting, U. Dafni, N.J. Latino, M. Galotti, P. Zygoura, G. Dimopoulou, T. Amaral, J. Barriuso, A. Calles, B. Kiesewetter, C. Gomez-Roca, B. Gyawali, M. Piccart, A. Passaro, F. Roitberg, N. Tarazona, D. Trapani, G. Curigliano, R. Wester, G. Zarkavelis, C. Zielinski, E.G.E. de Vries.

You can read the Full Article in Annals of Oncology.

ESMO-MCBS

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Societies

OncoDaily

Societies

How does ESMO-MCBS v2.0 Reflect the Evolving Oncology Treatment Landscape?